ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
2,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
4,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
5,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
6,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
6,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
7,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
8,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
9,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
9,2,Mouth haemorrhage,Oral soft tissue haemorrhages,Oral soft tissue conditions,Gastr,N
10,1,Activated partial thromboplastin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
10,2,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
10,3,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
10,4,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
10,5,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
11,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
12,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
13,1,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
14,1,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
15,1,Mouth haemorrhage,Oral soft tissue haemorrhages,Oral soft tissue conditions,Gastr,N
15,2,Post procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
16,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
17,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
17,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
18,1,Activated partial thromboplastin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
18,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
19,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
20,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
21,1,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
22,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
23,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
24,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
25,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,Y
26,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
26,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
27,1,Aortic dissection,Aortic aneurysms and dissections,Aneurysms and artery dissections,Vasc,N
27,2,Cardio-respiratory arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
27,3,Pericardial haemorrhage,Pericardial disorders NEC,Pericardial disorders,Card,Y
28,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
28,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
28,3,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,Y
29,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
30,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
30,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
31,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
32,1,Cerebral haematoma,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
32,2,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
32,3,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
32,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
33,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
34,1,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
35,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
36,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
37,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
37,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
38,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,Y
38,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
38,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
39,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
40,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
40,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
41,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
42,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
43,1,Lower gastrointestinal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
44,1,Large intestinal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
45,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
46,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
46,2,Tongue ulceration,Tongue disorders,Tongue conditions,Gastr,N
47,1,Splenic rupture,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
48,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
49,1,Activated partial thromboplastin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
49,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
49,3,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
49,4,Prothrombin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
49,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
50,1,Intraventricular haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
50,2,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
51,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
52,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
53,1,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
54,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
54,2,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
55,1,Activated partial thromboplastin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
55,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
56,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
57,1,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,Y
58,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
58,2,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
58,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
59,1,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
60,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
61,1,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
62,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
63,1,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
63,2,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
63,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
64,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
65,1,Mouth haemorrhage,Oral soft tissue haemorrhages,Oral soft tissue conditions,Gastr,N
65,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
66,1,Activated partial thromboplastin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
66,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
67,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
68,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
68,2,Haemorrhage subcutaneous,Skin haemorrhages,Skin vascular abnormalities,Skin,N
68,3,Haemothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
68,4,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
68,5,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
69,1,Activated partial thromboplastin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
70,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
70,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
71,1,Blood pressure systolic increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
71,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
72,1,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
72,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
73,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
74,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
75,1,Intracranial haematoma,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
76,1,Activated partial thromboplastin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
76,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
77,1,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
78,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
79,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
79,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
80,1,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,Y
81,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
82,1,Blindness unilateral,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
82,2,Hyphaema,Eye injuries NEC,Injuries NEC,Inj&P,N
83,1,Activated partial thromboplastin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
84,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
85,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
85,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
85,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
85,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
86,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
87,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
88,1,Splenic haemorrhage,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
88,2,Splenic infarction,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
89,1,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
89,2,Mouth haemorrhage,Oral soft tissue haemorrhages,Oral soft tissue conditions,Gastr,N
90,1,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
91,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
92,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
93,1,Colitis ischaemic,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
93,2,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
93,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
94,1,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
95,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
96,1,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
97,1,Activated partial thromboplastin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
98,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
99,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
99,2,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
99,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
100,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
101,1,Activated partial thromboplastin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
101,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
101,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
102,1,Activated partial thromboplastin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
103,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
104,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
104,2,Activated partial thromboplastin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
104,3,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
104,4,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
105,1,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
105,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
105,3,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
105,4,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
106,1,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
107,1,Haemorrhagic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
108,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
108,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
109,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
110,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
111,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
112,1,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
112,2,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
112,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
113,1,Activated partial thromboplastin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
113,2,Prothrombin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
113,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
114,1,Coagulation time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
114,2,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
114,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
115,1,Oesophageal ulcer haemorrhage,Oesophageal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
116,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
116,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
116,3,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
117,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
118,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
119,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
120,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
120,2,Activated partial thromboplastin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
120,3,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
120,4,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
121,1,Activated partial thromboplastin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
121,2,Prothrombin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
122,1,Activated partial thromboplastin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
122,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
123,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
124,1,Haemothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
125,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
126,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
127,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
128,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
129,1,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
130,1,Activated partial thromboplastin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
130,2,Chest X-ray abnormal,Respiratory tract and thoracic imaging procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
130,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
130,4,Rales,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
131,1,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
132,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
132,2,Pulseless electrical activity,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
133,1,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
134,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
135,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
136,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
137,1,Conjunctival haemorrhage,Conjunctival and corneal bleeding and vascular disorders,Ocular haemorrhages and vascular disorders NEC,Eye,N
137,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
138,1,Electrocardiogram ST segment elevation,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
138,2,Myopericarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
139,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
140,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
140,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
141,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
141,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
142,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
143,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
143,2,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
144,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
145,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
145,2,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
145,3,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
145,4,Toxic shock syndrome,Infections NEC,Infections - pathogen unspecified,Infec,N
146,1,Electrocardiogram ST segment elevation,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
147,1,Electrocardiogram ST segment elevation,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
148,1,Electrocardiogram ST segment elevation,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
149,1,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
149,2,Livedo reticularis,Skin vasomotor conditions,Skin vascular abnormalities,Skin,N
149,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
150,1,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
151,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
151,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
152,1,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
153,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
153,2,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
154,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
154,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
154,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
155,1,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
156,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
156,2,Septic embolus,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
156,3,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
157,1,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
158,1,Basal ganglia haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
158,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
159,1,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
160,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
161,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
161,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
162,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
163,1,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
163,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
164,1,Activated partial thromboplastin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
165,1,Brain herniation,Cerebral injuries NEC,Injuries NEC,Inj&P,Y
165,2,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
165,3,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
165,4,Pupil fixed,Pupil disorders,Ocular neuromuscular disorders,Eye,N
165,5,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
166,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
167,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
167,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
167,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
168,1,Duodenal ulcer haemorrhage,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
169,1,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
170,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
170,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
171,1,Brain herniation,Cerebral injuries NEC,Injuries NEC,Inj&P,Y
171,2,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
171,3,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
171,4,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
172,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
173,1,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
173,2,Uterine perforation,Reproductive tract and breast procedural complications,Procedural related injuries and complications NEC,Inj&P,N
174,1,Activated partial thromboplastin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
175,1,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
176,1,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
177,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
178,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
